Module 1: Pharmacological Impacts and Cardiovascular Systems Knowledge Check 1

Back to Module 1: Pharmacological Impacts and Cardiovascular Systems
Knowledge Check 1

This Knowledge Check serves as an assessment designed to reinforce your understanding of foundational pharmacotherapeutic concepts as they apply to cardiovascular care at the master’s level. Its primary purpose is to help you gauge your grasp of key topics such as pharmacokinetics, pharmacodynamics, drug interactions, and the clinical application of these principles in patient scenarios. By engaging with scenario-based and open-book questions, you will have the opportunity to apply theoretical knowledge to practical situations, preparing you for more complex assessments and real-world clinical decision-making.

The study questions provided for this module are closely aligned with the content and structure of the Knowledge Check. As you work through the required readings and study questions, you will build a strong conceptual foundation and develop the critical thinking skills necessary for success on the assessment. It is recommended that you use the study questions as a guide for your review, ensuring you can confidently analyze patient cases, anticipate adverse effects, and justify your clinical decisions. Dedicating focused time to these preparatory activities will not only support your performance on the Knowledge Check but also enhance your readiness for subsequent assignments and exams.

Level 1: No AI Permitted

AI tools may not be used at any stage
Common for clinical documentation or performance‑based work

Resources

Be sure to review the Learning Resources before completing this assessment.

Required Resources
To prepare:

Utilize course resources, clinical practice guidelines, and scholarly sources published within the past 5 years to answer the study questions and prepare for the Knowledge Check.
By Sunday of Week 1
Complete the Knowledge Check.

TAKE THE QUIZ TO FOLLOW LATER

THE QUIZ:

Flag question: Question 1
Question 11 pts
A 78-year-old male with chronic kidney disease is started on a renally cleared antibiotic. Which pharmacokinetic process is most directly impacted by his renal dysfunction?
Group of answer choices

. Absorption

. Distribution

. Metabolism

. Excretion

2) An advanced practice provider prescribes oral propranolol. Which of the following best explains why a higher oral dose is needed compared to the intravenous form?
Group of answer choices

. It undergoes zero-order kinetics

. It has poor gastrointestinal absorption

. It undergoes significant first-pass metabolism

.It is a highly protein-bound drug

3)Question 3. 1 pts
A patient with hypoalbuminemia is prescribed phenytoin, a highly protein-bound drug. What is the most likely pharmacologic consequence?
Group of answer choices

. Increased drug excretion

I. Increased free (active) drug levels

. Decreased half-life

. Decreased therapeutic effect
Question 4 1 pts
A drug has a narrow therapeutic index. Which of the following best describes how this characteristic should influence prescribing?
Group of answer choices

. Use the lowest cost version of the drug

. Avoid monitoring due to safety

. Dose adjustments are rarely needed

.Monitor plasma drug levels closely to avoid toxicity

Question 5. 1 pts
A patient develops reduced response to a beta-agonist after repeated use over a short period. This phenomenon is best described as:
Group of answer choices

. Dependence

. Tolerance

. Tachyphylaxis

.Desensitization

Question 6. 1 pts
A 45-year-old patient is an ultra-rapid metabolizer of CYP2D6. What is the clinical implication if they are prescribed codeine?
Group of answer choices

. They will have reduced analgesic effect

. They are at risk for exaggerated morphine effects

. The drug will not be absorbed effectively

. Codeine is unaffected by CYP2D6 activity

Question 7. 1 pts
Which of the following is an example of a pharmacodynamic drug interaction?
Group of answer choices

. Warfarin’s international normalized ratio increases when combined with fluconazole

. NSAIDs reduce the antihypertensive effect of ACE inhibitors

. CYP3A4 induction reduces efficacy of oral contraceptives

. Antacids reduce absorption of levothyroxine

Question 8. 1 pts
Which ethical principle is most directly upheld when a patient is given complete information about the risks and benefits of a new medication?
Group of answer choices

. Beneficence

. Justice

. Autonomy

. Fidelity

Question 9. 1 pts
A nurse practitioner prescribes gabapentin off-label for chronic cough. What must be considered in this context?
Group of answer choices

. FDA approval is required before prescribing off label

. Off-label use is illegal in advanced practice

. Evidence-based rationale and documentation are essential

. Off-label prescribing voids liability coverage

Question 10. 1 pts
A patient is prescribed a new medication and is concerned about cost. Which of the following best reflects an evidence-based approach for the provider?
Group of answer choices

. Prescribe only brand-name drugs to ensure effectiveness

. Ignore cost to avoid influencing clinical decisions

. Discuss therapeutic alternatives, including generics and formulary options

. Refer the patient to a pharmacist for all cost-related concerns